2010PubMedRequires access

[The role of CR1 complement receptor in pathology].

Aleksandra Rochowiak, Zofia I Niemir

Open publisher page 5 citations

Abstract

CR1 (Complement Receptor 1, CD35) is a membrane receptor for C3b and C4b expressed on erythrocytes, leukocytes and podocytes. It plays an important role in removal of immune complexes and pathogens coated with C3b and C4b. It also regulates the complement cascade activation by preventing formation of classical and alternative pathway convertases and by acting as a cofactor for factor 1 mediated cleavage of C3b to iC3b, C3c and C3dg. CR1 is a polymorphic molecule differing in molecular weight and the level of the CR1 expression on erythrocytes. It takes part in pathogenesis and development of various autoimmune and infectious diseases. The difference in expression of CR1 seems to correlate directly with the development of systemic lupus erythematosus (SLE) and severe form of malaria. The therapeutical potential of soluble CR1 (sCR1) is at present the subject of many investigations.

About this research paper

What this paper is about

CR1 (Complement Receptor 1, CD35) is a membrane receptor for C3b and C4b expressed on erythrocytes, leukocytes and podocytes. It plays an important role in removal of immune complexes and pathogens coated with C3b and C4b. It also regulates the complement cascade activation by preventing formation of classical and alternative pathway convertases and by acting as a cofactor for factor 1 mediated cleavage of C3b to iC3b, C3c and C3dg. CR1 is a polymorphic molecule differing in molecular weight and the level of the CR1 expression on erythrocytes. It takes part in pathogenesis and development of various autoimmune and infectious diseases. The difference in expression of CR1 seems to correlate directly with the development of systemic lupus erythematosus (SLE) and severe form of malaria. The therapeutical potential of soluble CR1 (sCR1) is at present the subject of many investigations.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

CR1 (Complement Receptor 1, CD35) is a membrane receptor for C3b and C4b expressed on erythrocytes, leukocytes and podocytes. It plays an important role in removal of immune complexes and pathogens coated with C3b and C4b. It also regulates the complement cascade activation by preventing formation of classical and alternative pathway convertases and by acting as a cofactor for factor 1 mediated cleavage of C3b to iC3b, C3c and C3dg. CR1 is a polymorphic molecule differing in molecular weight and the level of the CR1 expression on erythrocytes. It takes part in pathogenesis and development of various autoimmune and infectious diseases. The difference in expression of CR1 seems to correlate directly with the development of systemic lupus erythematosus (SLE) and severe form of malaria. The therapeutical potential of soluble CR1 (sCR1) is at present the subject of many investigations.

Key concepts: iC3b, Complement receptor, Complement system, Complement factor I, Complement receptor 1, Alternative complement pathway, Immune system, Pathogenesis

Related papers

Back to paper searchBrowse research topicsOriginal source
[The role of CR1 complement receptor in pathology]. — Research Paper | ScholarLens